Related Articles
ABCB1 haplotypes are associated with P‑gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib
BTK acts as a modulator of the response to imatinib in chronic myeloid leukemia
TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β‑catenin/TCF7/ABC transporter signaling axis
Dynein axonemal heavy chain 9 M4374I variation may have an effect on imatinib mesylate resistance in CML
TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation